Food and Drug Administration issues an Actos cancer warning during the period of September 2010. During that time, they reviewed data from the ongoing ten-year-old study designed to verify that whether Actos may increase the risk of bladder cancer. FDA had information, which indicates that patients with the longest exposure and highest dose of Actos were found in increased risk of bladder cancer. France has completed a large epidemiological study which concurred with the review of bladder cancer. The main actos warnings were not to use Actos in patients with active bladder cancer. You should use Actos with caution in patients who have a history of bladder cancer. This agency recommends physicians and counsel patients about various syndromes of bladder cancer. This encourages various patients to read about the medication guide and to become aware about the various side effects of Actos. In case of any problems in relation to Actos warnings, you can always contact Actos lawyers for getting compensation.
(Sponsored attorney advertising)